This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Adarx Pharmaceuticals, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Zhiqing (Joel) Zhou: Innovator in Prekallikrein Modulation
Introduction
Zhiqing (Joel) Zhou is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biochemistry, particularly in the modulation of plasma prekallikrein. His innovative work has the potential to impact various therapeutic applications.
Latest Patents
Zhou holds a patent for "Prekallikrein-modulating compositions and methods of use thereof." This patent encompasses compounds, compositions, and methods designed to modulate the expression or activity of plasma prekallikrein (PKK). The disclosed methods can effectively reduce the expression of PKK mRNA and protein in cells or animals, showcasing the potential for therapeutic interventions.
Career Highlights
Zhiqing (Joel) Zhou is currently associated with Adarx Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at Adarx Pharmaceuticals focuses on innovative solutions in the pharmaceutical industry, contributing to the development of new therapies.
Collaborations
Zhou collaborates with talented professionals in his field, including Zhen Li and Rui Zhu. These collaborations enhance the research environment and foster innovation within the company.
Conclusion
Zhiqing (Joel) Zhou is a prominent inventor whose work in prekallikrein modulation holds promise for future therapeutic advancements. His contributions to the field are noteworthy and reflect his commitment to innovation in biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile